{
    "code": "02000633",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02000633",
    "time": "2016-11-18 16:11:45",
    "許可證字號": "衛署藥輸字第000633號",
    "註銷狀態": "已註銷",
    "註銷日期": "73\/12\/31",
    "註銷理由": "安用科更新資料",
    "有效日期": "76\/04\/15",
    "發證日期": "61\/04\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00200063306",
    "中文品名": "泰維超注射液",
    "英文品名": "TAVEGYL AMPOULES",
    "適應症": "過敏及類似過敏性休克",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "CLEMASTINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1203901100  裕台企業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F430067000  MANUFACTURED BY R.P.SCHERER FOR NOVARTIS PHARMA AG",
        "製造廠廠址": "GAMMELSBACHER STR 2,D-69412 EBERBACH\/BADEN,GERMANY FOR CH-4002 BASEL,SWITZERLAND.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400001000",
            "成分名稱": "CLEMASTINE",
            "含量描述": "0.001",
            "含量": "0.0010000000",
            "單位": "GM"
        }
    ]
}